161 related articles for article (PubMed ID: 11036200)
1. Amyloid-like inclusions in Huntington's disease.
McGowan DP; van Roon-Mom W; Holloway H; Bates GP; Mangiarini L; Cooper GJ; Faull RL; Snell RG
Neuroscience; 2000; 100(4):677-80. PubMed ID: 11036200
[TBL] [Abstract][Full Text] [Related]
2. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington's, Alzheimer's, and Pick's diseases.
Singhrao SK; Thomas P; Wood JD; MacMillan JC; Neal JW; Harper PS; Jones AL
Exp Neurol; 1998 Apr; 150(2):213-22. PubMed ID: 9527890
[TBL] [Abstract][Full Text] [Related]
3. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
4. Insoluble TATA-binding protein accumulation in Huntington's disease cortex.
van Roon-Mom WM; Reid SJ; Jones AL; MacDonald ME; Faull RL; Snell RG
Brain Res Mol Brain Res; 2002 Dec; 109(1-2):1-10. PubMed ID: 12531510
[TBL] [Abstract][Full Text] [Related]
5. Inclusions of R6/2 Mice Are Not Amyloid and Differ Structurally from Those of Huntington Disease Brain.
André W; Sandt C; Nondier I; Djian P; Hoffner G
Anal Chem; 2017 May; 89(10):5201-5209. PubMed ID: 28398721
[TBL] [Abstract][Full Text] [Related]
6. Implications of the Orb2 Amyloid Structure in Huntington's Disease.
Hervás R; Murzin AG; Si K
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967102
[TBL] [Abstract][Full Text] [Related]
7. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.
Scherzinger E; Sittler A; Schweiger K; Heiser V; Lurz R; Hasenbank R; Bates GP; Lehrach H; Wanker EE
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4604-9. PubMed ID: 10200309
[TBL] [Abstract][Full Text] [Related]
8. Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers.
Hoffner G; Island ML; Djian P
J Neurochem; 2005 Oct; 95(1):125-36. PubMed ID: 16181417
[TBL] [Abstract][Full Text] [Related]
9. Structure of inclusions of Huntington's disease brain revealed by synchrotron infrared microspectroscopy: polymorphism and relevance to cytotoxicity.
André W; Sandt C; Dumas P; Djian P; Hoffner G
Anal Chem; 2013 Apr; 85(7):3765-73. PubMed ID: 23458159
[TBL] [Abstract][Full Text] [Related]
10. Bioenergetics in Huntington's disease.
Grünewald T; Beal MF
Ann N Y Acad Sci; 1999; 893():203-13. PubMed ID: 10672239
[TBL] [Abstract][Full Text] [Related]
11. Global changes to the ubiquitin system in Huntington's disease.
Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
[TBL] [Abstract][Full Text] [Related]
12. Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease.
Díaz-Hernández M; Torres-Peraza J; Salvatori-Abarca A; Morán MA; Gómez-Ramos P; Alberch J; Lucas JJ
J Neurosci; 2005 Oct; 25(42):9773-81. PubMed ID: 16237181
[TBL] [Abstract][Full Text] [Related]
13. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
[TBL] [Abstract][Full Text] [Related]
14. Atypical Huntington's disease with the clinical presentation of behavioural variant of frontotemporal dementia.
Sutovsky S; Smolek T; Alafuzoff I; Blaho A; Parrak V; Turcani P; Palkovic M; Petrovic R; Novak M; Zilka N
J Neural Transm (Vienna); 2016 Dec; 123(12):1423-1433. PubMed ID: 27287334
[TBL] [Abstract][Full Text] [Related]
15. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.
Becher MW; Kotzuk JA; Sharp AH; Davies SW; Bates GP; Price DL; Ross CA
Neurobiol Dis; 1998 Apr; 4(6):387-97. PubMed ID: 9666478
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.
Tabrizi SJ; Workman J; Hart PE; Mangiarini L; Mahal A; Bates G; Cooper JM; Schapira AH
Ann Neurol; 2000 Jan; 47(1):80-6. PubMed ID: 10632104
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-like features of polyglutamine aggregates and their assembly kinetics.
Chen S; Berthelier V; Hamilton JB; O'Nuallain B; Wetzel R
Biochemistry; 2002 Jun; 41(23):7391-9. PubMed ID: 12044172
[TBL] [Abstract][Full Text] [Related]
18. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
[TBL] [Abstract][Full Text] [Related]
19. Protein misfolding detected early in pathogenesis of transgenic mouse model of Huntington disease using amyloid seeding assay.
Gupta S; Jie S; Colby DW
J Biol Chem; 2012 Mar; 287(13):9982-9989. PubMed ID: 22187438
[TBL] [Abstract][Full Text] [Related]
20. Is Huntington's disease a tauopathy?
Gratuze M; Cisbani G; Cicchetti F; Planel E
Brain; 2016 Apr; 139(Pt 4):1014-25. PubMed ID: 26969684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
